Circumventing Immunogenicity in Gene Therapy With Svec, a Novel SV40 Based Viral Vector Platform
Time: 2:30 pm
day: Day 2 Track 1 PM
Details:
- The crucial role of immunity and tolerance in gene therapy
- Features and development of the SVec platform in Haemophilia
- Opening new frontiers in gene therapy: Potential to restore tolerance in autoimmunity
